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Abstract.  Human mesothelial cells, endothelial cells, 
and type II kidney epithelial cells growing in culture 
devote •3  % of their total protein synthesis to the 
production of an Mr *46-kD,  pI 7.1, secreted glyco- 
protein (designated Sp46).  Fibroblasts make about 
1/10th as much Sp46 as these cell types, and their syn- 
thesis is dependent upon hydrocortisone. Keratino- 
cytes, urothelial cells, conjunctival epithelial cells, and 
mammary epithelial cells do not make detectable 
amounts of Sp46.  Mesothelial cells secrete Sp46 onto 
the substratum, and from there it is subsequently 
released into the medium. Immunofluorescence analy- 
sis using specific antisera discloses that Sp46 is depos- 
ited beneath cells as a  fine coating on the substratum. 
In sparse cultures, Sp46 is detected in trails behind 
motile cells. In contrast, secreted fibronectin coalesces 
into fibers, most of which remain in contact with and 
on top of the cells; thus Sp46 does not preferentially 
bind to fibronectin. About 6 kD of the mass of human 
Sp46 is N-linked oligosaccharide, which is terminally 
sialated before secretion. Sp46 has a  low glycine con- 
tent, indicating that it is not a  collagenlike protein. Its 
NH2-terminal sequence over the first 40 amino acids 
does not resemble any protein for which sequence in- 
formation is available. S1M6 appears to be a  novel ex- 
tracellular glycoprotein, high-level constitutive expres- 
sion of which is restricted to mesoderm-derived 
epithelial and endothelial cells. We therefore propose 
for it the name "mesosecrin" 
M 
ANY differentiation-related proteins made by so- 
matic cells are secreted, rather than remaining as 
permanent cellular constituents. A  secreted pro- 
tein may perform its function for the cell that synthesizes it, 
or for other cells in the immediate vicinity (e.g., extracellu- 
lar matrix proteins such as collagens, fibronectin, and lami- 
nin; or clotting factors and wound repair growth factors such 
as those released by platelets). Alternatively, a secreted pro- 
tein may enter the general circulation and act at a  great 
distance from the cell that produces it (e.g., polypeptide hor- 
mones, immunoglobulins, and serum albumin). In examin- 
ing the intact animal, it is often difficult to identify the cell 
responsible for secreting a particular protein, whether it is 
in the general circulation or in the extracellular matrix of a 
tissue. It is also possible for a prominent secreted protein 
made by a particular cell type to remain undiscovered. This 
might occur if the protein is produced only under special cir- 
cumstances,  is  produced by a  small  number  of cells,  is 
quickly altered or cleared, or if it is simply diluted by the 
total blood volume of the animal. 
The study of pure cell populations in culture can circum- 
vent these problems. We have been studying several normal 
human epithelial cell types in serial culture in order to iden- 
tify differentiation and growth control phenotypes that are 
epithelial-specific or are characteristic of  only certain epithe- 
lial cell types. One of these cell types is the mesothelial cell, 
which forms the simple squamous epithelium that lines the 
inner body cavities (pleura, pericardium, and peritoneum) 
and covers the organs contained therein. Mesothelial cells 
occasionally detach from their epithelium and are therefore 
present in fluid withdrawn from the body cavities.  Many of 
these cells are proliferative and can be serially cultivated and 
expanded into large populations in culture if provided with 
a  complex nutrient medium containing epidermal growth 
factor (EGF), ~ hydrocortisone (HC), and FCS (Wu et al., 
1982; Connell and Rheinwald, 1983; LaRocca and Rhein- 
wald, 1985). The mesothelial cell is rather unusual among 
the epithelia in that it is derived during development from 
the embryonic mesoderm, rather than the ectoderm or endo- 
derm.  The kidney cortex epithelial cells, which form the 
nephrons,  or  renal  tubule filtration system, arise  from a 
different region of the mesoderm. Two distinctive epithelial 
cell types proliferate in culture from explanted human kidney 
cortex (Rheinwald et al.,  1984; Rheinwald and O'Connell, 
1. Abbreviations  used in this paper: CM, conditioned medium; EGF, epi- 
dermal growth factor; HC, hydrocortisone;  M199, medium 199; THS, Tri- 
ton/high salt buffer; TTBS, Tween/Tris-buffered saline; 2D NEPHGE, two- 
dimensional nonequilibrium pH gradient electrophoresis. 
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are not identical to, mesothelial cells with respect to charac- 
teristics of growth regulation and intermediate filament pro- 
tein expression in culture. 
During our studies of the intermediate filament proteins of 
these cell types (Wu et al., 1982; our unpublished observa- 
tions) we noticed, in addition to vimentin and the four simple 
epithelial keratins, a prominent, metabolically labeled 46- 
kD protein in the Triton/high salt (THS)-insoluble fraction. 
We initially thought that this 46-kD protein was another ker- 
atin, but found in later pulse-chase experiments that it disap- 
pears from the cell extract soon after synthesis (Connell and 
Rheinwald, 1983). We report here that this protein is actually 
a glycoprotein which is initially secreted onto the substratum 
and subsequently accumulates in the medium. Next to [~-ac- 
tin, it is the most prominent protein synthesized by human 
mesothelial cells and several other mesoderm-derived cells 
in culture, and we therefore have named it "mesosecrin: 
Materials and Methods 
Normal Human Cell Strains and Culture Conditions 
Peritoneal mesothelial cell strains LP-9 and LP-3 (Vch et al.,  1982) and 
pleural mesothelial cell strain HPM-1 (cultured from pleural effusion fluid 
withdrawn from a 63-yr-old man) were cultured in a  1:1 (vol/vol) mixture 
of medium 199 (M199) and medium MCDB202 plus 15% FCS, 0.4 gg/ml 
HC, and 10 ng/mi EGE as described previously (Connell and Rheinwald, 
1983; LaRocca and Rbeinwald, 1985). In this paper, M199/MCDB202 plus 
15% FCS and HC will be referred to as "standard medium." (LP-9 and LP-3 
are now available as strain numbers AG7086 and AG7090, respectively, from 
the Aging Cell Repository of the Coriell Institute for Medical Research, 
Camden, NJ.) 
Fetal kidney cortex type I epithelial cell strain HKi-12 clone D and kidney 
cortex type H epithelial strains HKi-12 clone 2.1  (fetal) and HKi-14 clone 
8 (adul0 were cultured in standard medium plus EGE as described previ- 
ously (Rheinwald and O'Connell,  1985).  Dermal fibroblast strains A1-F 
(newborn), R2-F (adult), and P1-F (adult) (Didinsky and Rbeinwald, 1981; 
O'Connell and Rheinwald, manuscript in preparation) were cultured either 
in a 1:1 (vol/vol) mixture of DME (Flow Laboratories, Inc., McLean, VA) 
and FI2 (Gibco, Grand Island, NY) media plus 15% FCS, HC, and EGF 
or in standard medium plus EGE 
Epidermal  keratinocyte strain  N  (newborn)  (Rbeinwald and Beckett, 
1980) and A4-Ep (adult) (O'Connell and Rheinwald, manuscript in prepara- 
tion), adult urinary bladder urothelial strains HB1-4 and HBI-8 (Wu et al., 
1982; Rbeinwald et al.,  1984),  fetal conjunctival epithelial celt strain AX 
(Wu et al., 1982), and adult mammary epithelial cell strains Hl16 (754AB) 
and  H30  (464AA)  (both  initiated  from  collagenase-digested mammary 
gland cell clusters provided by Martha Stampfer, University of California, 
Berkeley) all were cultured in the presence of mitomycin-treated 313 mouse 
fibroblast feeder cells (Rheinwald and Green,  1975; Rheinwald, 1980) in 
DME/FI2 medium plus 5 % FCS, 0.4 ttg/mi HC,  10 ng/mi EGF,  10  -9 M 
cholera toxin (Schwarz-Mann, Orangeburg,  NY),  2  x  10  -s M  adenine, 
and 5 gg/ml insulin (Sigma Chemical Co., St. Louis, MO) as described pre- 
viously (Allen-Hoffman and Rheinwald, 1984; Wu et al.,  1982).  In some 
experiments, mammary epithelial cells were cultured without 3T3 feeder 
cells in standard medium plus EGE 
Two umbilical vein endothelial cell populations in early passage (kindly 
provided by Dr. Jordan Pober of Brigham and Women's Hospital, Boston, 
MA) were cultured in M199  plus 20%  FCS,  5  ttg/mi Endothelial Cell 
Growth Factor (Meloy Laboratories, Inc., Springfield, VA) and 10 gg/ml 
heparin (Sigma Chemical Co.) (Thornton et al.,  1983). 
Metabolic Labeling and Electrophoretic Separation 
of  Proteins 
Cultures were labeled for 1 h (unless otherwise indicated) with 50 ttCi/ml 
[asS]methionine (specific activity 800  Ci/mmol;  New England Nuclear, 
Boston, MA) in otherwise methionine-free MEM medium (Irvine Scien- 
tific,  Santa Ana, CA) supplemented with 10% dialyzed FCS and the same 
growth factors and hormones With which the cells had been cultured. Some 
labeled cultures were lysed immediately. Others were "chased" by replacing 
the labeling medium with unlabeled growth medium containing 1%  FCS 
and the appropriate growth factors, and returning the cultures to the incuba- 
tar for various periods of time before collecting the medium and lysing the 
cells. The conditioned medium (CM) from these chased cultures was exam- 
ined electrophoretically for secreted proteins. 
Cultures were dissolved in OTarrell lysis buffer, containing 8M urea 
(O'Farrell,  1975), or in Laemmli lysis buffer, containing SDS (Laemmli, 
1970), or they were lysed in THS, containing 20 mM Tris-HCl (pH 7.3), 
1% Triton X-100, 0.6 M KC1, 5 mM EDTA, and 1 mM phenylmethylsulfonyl 
fluoride (a modification of the THS buffers described previously) (Franke 
et al.,  1979; Wu et al.,  1982). THS-lysed cells were sonicated at 4°C and 
the insoluble "cytoskeletal"  fraction was separated from the soluble material 
by centrifugation at 5,000 g for 5 rain. THS-soluble and -insoluble fractions 
were dissolved in Laemmli lysis buffer and the proteins were separated by 
one-dimensional SDS  PAGE  (1D  SDS  PAGE)  in  10%  acrylamide  gels 
(Laemmli, 1970), or were dissolved in O'Farrell lysis buffer and separated 
by  two-dimensional,  nonequilibrium  pH  gradient  electrophoresis  (2D 
NEPHGE)  (O'Farrell  et  al.,  1977). Gels  were  stained  with  Coomas- 
sie Brilliant Blue R (Sigma Chemical Co.) in order to detect total protein. 
To  detect metabolically labeled proteins,  gels were soaked in the fluor 
EnHance (New England Nuclear), dried, and autoradiographed by placing 
against Kodak SB-5 X-ray film (Eastman Kodak Co., Rochester, NY). 
Glycoprotein Analysis 
Mannose-containing proteins were detected by labeling cells for 4 h with 
0.5 mCi/ml [2-3H]mannose (specific activity 50 Ci/mmol; New England 
Nuclear) in medium containing a reduced glucose concentration (50 I.tg/ 
mi).  To  block the addition of oligosaccharide to asparagine residues in 
potential glycoproteins, cells were preincubated with 0.25 gg/ml tunicamy- 
cin (Sigma Chemical Co.) for 24 h  and then were labeled for 1 h  with 
[35S]methionine  in the presence of tunicamycin. 
Asparagine-linked oligosaccharides (N-glycans) were cleaved from Sp46 
with endnglycosidase F  (Elder and Alexander, 1982).  Electrophoretically 
purified Sp46 was incubated with 1 U of endoglycosidase F (New England 
Nuclear) in a buffer consisting of 0.1 M sodium phosphate (pH 6.1), 0.05 
M  EDTA, 0.5%  NP40, 0.1%  SDS, and 1% 2-mercaptoethanol for 2 h at 
37°C.  Terminal sialic acid residues were removed from N-glycans by incu- 
bation with 50 mU of Vibrio cholerae neuraminidase (Calbiochem-Beltring 
Corp., San Diego, CA) in 50 raM sodium acetate buffer (pH 5.6) containing 
1 mM CaC12 for 24 h at 37°C. 
Purification of  Sp46/Mesosecrin from CM 
Cultures of LP-9 were grown to confluence in 100-mm diam dishes in stan- 
dard medium without EGE They then were rinsed twice with serum-free 
medium and incubated for 3  d  with 8 ml per dish of M199/MCDB202 
medium, 0.1% FCS, and 0.4 gg/ml HC. The CM was then harvested and 
the cultures were refed for 1 d with standard medium without EGE Then 
the medium was replaced with low serum medium for another 3-d incuba- 
tion. Immediately after collection, Hepes was added to a concentration of 
20 raM, the CM was passed through a 0.2-1~m sterilization filter (Nalge Co., 
Rochester, NY), and then was stored at 4°C for no more than 10 d. CM 
was concentrated 50-fold by pressure ultrafiltration over a PMI0 filter (Ami- 
con Corp., Danvers, MA) and dialyzed by diluting with 20 vol of 20 mM 
Tris-HC1 (pH 7.2) buffer and reconcentrating. Concentrated CM was stored 
at  -20°C. 
Aliquots of concentrated CM were separated by 1D SDS-PAGE, the gels 
were stained with Coomassie Blue, the 46-kD band was excised with a razor 
blade, and the Sp46 was electroeluted in an Isco model 1750 sample concen- 
trator (Isco,  Inc.,  Lincoln, NE).  Purity of the Sp46 was determined by 
separating an aliquot of electroeluted material on another gel, and its con- 
centration was estimated by comparing its Coomassie Blue staining intensity 
on gels with that of BSA standards of known concentration. 
In later preparations, concentrated CM was mixed with concanavalin A 
(Con A)-Sepharose beads (Pharmacia, Inc., Piscataway,  NJ), which had 
been equilibrated in 20 mM Tris-HC1 buffer (pH 7.3),  0.5 M NaC1,  1 mM 
CaCI2, and 1 mM MnCl2.  The beads were then rinsed twice in this buffer, 
and bound proteins were eluted by the addition of ct-methylmannoside to 
0.5 M. The eluted proteins were concentrated by ultrafiltration and Sp46 
purified from this material by preparative 1D SDS PAGE as described by 
Hunkapillar et al. (1983) to minimize cleavage and chemical modification. 
Electrophoresis-grade gel and buffer reagents from BioRad Laboratories 
(Richmond, CA) and Sigma Chemical Co. were used, and electrophoresis 
was performed in the presence of 0.1 M sodium thioglycolate. Sp46 was lo- 
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Fine Biochemicals, Inc., Garden City Park, NY) in acetic acid/isopropa- 
nol/water (1:3:6,  vol/vol/vol), and the bands were excised. The Sp46 was 
electroeluted  and  then  electrodialyzed  against  0.01 M  NH4HCO3  and 
0.02%  SDS. This material was used for amino acid analysis and NH2-ter- 
minal sequencing. 
Preparation of  Antisera 
Two rabbits were immunized by three subcutaneous injections of 100 ~tg of 
gel-purified Sp46.  Because the antisera cross-reacted with some 60-70 kD 
FCS proteins in immunoblot experiments, the antiserum from one rabbit 
(J1) was passed through a  column of FCS  protein covalently linked to 
cyanogen-Sepharose  beads (Pharmacia Fine Chemicals). The unbound frac- 
tion exhibited greatly reduced cross-reaction with serum proteins in immu- 
noblots but undiminished reactivity to Sp46. Two mice were immunized by 
four injections of 30-50 ~tg of S1M6. 
Immunochemical Methods 
Immunoprecipitation.  [35S]methionine-labeled  THS-soluble cell protein, 
CM, and purified Sp46 were diluted to a final volume of 0.4 mi in 20 mM 
Tris-HC1 (pH 7.35) buffer containing 0.14 M NaC1, 2 mM EDTA, and 0.5% 
NP-40. 5 ~tl of undiluted antiserum was then added and the solution was in- 
cubated for 30 min at room temperature. Then 50 txl of hydrated protein 
A-Sepharose beads (Pharmacia Fine Chemicals) was added and the mixture 
was incubated for 30 min with shaking. The beads and hound material were 
pelleted in a microcentrifuge and rinsed twice with neutral, isotonic PBS. 
The beads were then treated with 100 Ixl of either O'Farrelt lysis buffer or 
twice-concentrated Laemmli sample buffer, the eluted material was sepa- 
rated electrophoretically, and the immunoprecipitated labeled proteins were 
detected by autoradiography. 
Immunoblotting.  Proteins were blotted onto nitrocellulose paper from 
ID slab gels by electrotransfer using an E-C Apparatus Corp. (St.  Peters- 
burg, FL) electroblot set at 300 mA for 2 h at 4°C. Blots were stained with 
0.1%  Fast Green in methanol/acetic acid,  destained in water,  and pho- 
tographed. Blots were preblocked by soaking them in a buffered solution 
of nonfat dry milk (Blotto) (Johnson et al., 1984) for at least 1 h, and were 
sometimes stored in Blotto overnight before use. Blots were incubated for 
1 h  at  room temperature with antiserum diluted  1:1,000 in Tween/Tris- 
buffered saline (TTBS), which consisted of  0.05 % Tween-20 in 50 mM Tris 
and 150 mM NaC1 (pH 8.0).  After rinsing for 15 min in TTBS, the blots 
were incubated for 1 h with biotinylated secondary antibody (Vector Labo- 
ratories, Inc., Burlingame, CA) diluted 1:200 in TTBS, rinsed in TTBS for 
15 min, and then incubated in the avidin-biotin peroxidase complex (Vector 
Laboratories) for 30 min. The blots were then rinsed in 50 mM Tris-HCl 
(pH 7.6) for 15 rain and immersed in a freshly prepared solution of 0.01% 
hydrogen peroxide plus 50 ~tg/mi diaminobenzidine (Sigma Chemical Co.) 
in 50 mM Tris-HC1 (pH 7.6) for 5-15 min. When the bands containing anti- 
gen were suitably dark, the reaction was stopped by rinsing in distilled water 
and air-drying. 
Indirect lmmunofluorescence 
Cultures grown on plastic dishes were fixed for 10 rain to 1 mo in -20°C 
methanol, or were fixed for 10 min in 3.7% forrnaldehyde/PBS followed by 
a 2-rain treatment with 0.5% Triton X-100 in PBS. Cultures were then rinsed 
in PBS, briefly air-dried, and incubated with antiserum (diluted 1:30 to 1:50 
in PBS) for 30 min at room temperature. The cultures then were rinsed for 
15 rain in PBS, incubated with fluorescent secondary antibody for 30 rain, 
rinsed for 30 min in PBS, and mounted under coverslips with glycerin jelly 
(Sigma Chemical Co.) containing 1 mg/mi p-phenylenediamine to reduce 
photobleaching (Johnson and Noguiera-Araujo, 1981). Cells were examined 
for immunofluorescence with a  Zeiss epifluorescence microscope (Carl 
Zeiss, Inc., Thornwood, NY)  equipped with rhodamine and fluorescein 
barrier filters and a  ×25 immersion objective. 
Microscopy and Photography 
Cells processed for immunofluorescence  were photographed on Kodak Tech 
Pan 2415 film exposed at ASA 160 for phase-contrast and fluorescein im- 
munofluorescence, and at  ASA 80  for rhodamine immunofluorescence. 
Stained gels, blots, and autoradiograms were photographed on Tech Pan film 
exposed at ASA 80. Coomassie Blue-stained gels were photographed through 
an orange filter,  Fast Green-stained blots through a red filter, and peroxi- 
dase/diaminobenzidine-reaeted  blots through a blue filter.  Film was devel- 
oped in Kodak D19 developer. 
Results 
Mesothelial Cells Synthesize a 46-kD Protein at a 
High Rate and Secrete It into the Medium 
Cultures of the normal human mesothelial cell strain LP-9 
were labeled for  1 h  with [35S]methionine  and then were 
refed with unlabeled medium. The cells, the substratum- 
associated material, and the culture medium (CM) were ex- 
amined at various times thereafter by SDS PAGE (Fig.  1), 
which disclosed a  secreted protein of apparent molecular 
mass 46 kD (size estimated by its coelectrophoresis with the 
46-kD keratin no. 17 of cultured human epidermal keratino- 
cytes [Sun and Green, 1978; Fuchs and Green, 1978; see also 
Moll et al., 1982]) (data not shown). Scans of the autoradio- 
grams indicated that this-protein represented ~3% of total 
protein  synthesis and was  the major protein  secreted by 
mesothelial cells. (In the Results section we will hereafter re- 
fer to this 46-kD secreted protein as Sp46.)  Even after only 
1 h  of labeling, 35 % of the Sp46  synthesized during that 
period had already been secreted by the cells onto the culture 
vessel surface (Fig. 1). During the first hour after the label 
was removed from the medium, slightly higher levels of the 
previously synthesized Sp46 accumulated on the dish. Then 
over the subsequent 6 h almost all of the dish-associated, la- 
beled Sp46 material was released into the medium. Its half- 
life of association with the substratum was '~2 h. The Sp46 
that accumulated in the medium was not significantly de- 
graded for at least several days. Similar kinetics of secre- 
tion and movement of Sp46 from the substratum into the 
medium were measured for cells at preconfluence or post- 
confluence, in the presence or absence of EGE or when cul- 
tured on standard tissue culture dishes (negatively charged 
surface)  vs.  positively charged  dishes  (Primaria,  Falcon 
Plastics, Oxnard, CA). 
Glycosylation, Processing, and Secretion of  Sp46 
Sp46 is a glycoprotein, as evidenced by its metabolic labeling 
with [3H]mannose  and by its binding to the mannose-spe- 
cific lectin Con A  (Fig.  2).  Sp46  could be  concentrated 
from CM and purified from the major serum contaminant, 
BSA, by elution from Con A-Sepharose beads with a-methyl- 
mannoside. 
2D NEPHGE separation of labeled cell proteins revealed 
size and charge heterogeneity of Sp46 within the cell prior 
to secretion (Fig. 3 A). Extracts of cells that were labeled for 
1 h contained two major forms, one of pI 7.4 and one which 
migrated as a slightly larger ('~1 kD) protein ofpI 7.1. (Iso- 
electric points were estimated by migration in NEPHGE of 
Sp46 relative to the 56-kD keratin no. 6 and the 58-kD kera- 
tin no. 5 during coelectrophoresis with the THS-insoluble 
fraction of cultured human bladder urothelial cells (Wu et 
al.,  1982; Rheinwald et al.,  1984; see  also  Moll et al., 
1982)(data  not shown).  Both labeled species disappeared 
from the cells during an overnight chase and a labeled pro- 
tein of size and charge identical to that of the larger, more 
acidic cellular form appeared in the medium. These experi- 
ments also revealed that mesothelial cells synthesize Sp46 at 
the same rate when growing rapidly in the presence of EGF 
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cumulation in the medium.  (A) A set of LP-9 cultures that had 
just reached confluence in the presence of EGF was labeled with 
[35S]Met for 1 h. One culture was immediately rinsed, the cells 
were detached from the dish with EDTA, and the cells (lane 1) and 
dish surface (lane 2) were extracted with Laemmli SDS lysis buffer. 
The remaining cultures were refed with unlabeled medium and 
returned to the incubator. At various times thereafter (0.5 h, lanes 
3 and 4; 1 h, lanes 5 and 6; 3 h, lanes 7 and 8; 6 h, lanes 9 and 
10; and 24 h, lanes//, 12, and 13), the medium was harvested from 
one of these cultures, the cells were removed with EDTA, and the 
dish surface was extracted with SDS buffer. 1/40th of the total vol- 
ume of cell extract (lanes 1 and 13), of the CM (lanes 3, 5, 7, 9, 
and//), and of the dish extract (lanes 2, 4, 6, 8, 10, and 12) were 
separated by SDS PAGE and autoradiographed. Asterisk indicates 
Sp46;  a  indicates actin;  arrowhead  indicates fibronectin.  (B) 
Graphic depiction of the experiment shown in A, quantitated by 
scanning gels of appropriate dilutions of each sample. 
as they do when quiescent at confluence in the absence of 
EGF (compare panels a  and c  of Fig.  3  A).  In contrast, 
fibronectin was synthesized at much higher levels by rapidly 
growing than by quiescent cells. 
To study the intracellular processing of Sp46 more closely, 
cells were pulse-labeled for various lengths of time and ei- 
ther extracted immediately or after a brief chase in unlabeled 
medium. 2D NEPHGE separation of proteins (Fig. 3 B) re- 
vealed that Sp46 is translated as the smaller, more basic form 
and then during the next 1-2 h is converted within the cell 
to  the  larger,  more  acidic  form that  is  secreted into  the 
medium.  A  minor intracellular form, intermediate in size 
and charge between the initially synthesized and the ulti- 
mately secreted forms, was detectable in some well-resolved 
electrophoretic separations of 1-h pulse-labeled cell proteins 
(Fig. 3 B, panel b). All three forms were immunoprecipitated 
(Fig. 3 B, panel d) by an anti-Sp46 antiserum (described be- 
low), thus confirming their identity as processing intermedi- 
ates of Sp46. 
A very minor form (indicated by the small arrowhead in 
Fig. 3 A, panel e, and Fig. 3 B, panel b), slightly larger and 
more acidic than the predominant secreted form, was also 
detectable (Fig. 3 A, panels e and f) in heavily labeled cell 
extracts and in  some CM  samples.  This form was prefer- 
entially retained by the substratum, as revealed by electro- 
phoretic and immunochemical analysis of labeled material 
remaining  dish-associated  after  a  24-h  chase  (data  not 
shown). This form was produced as a higher proportion of 
the total Sp46 synthesized by type II kidney epithelial cell ex- 
tracts and CM, representing ,025 % of the total Sp46 secreted 
by this cell type (see below). 
Tunicamycin inhibits the coupling of  N-acetylglucosamine 
(GlcNAc)  to  dolichol  (see  Duksin  and  Mahoney,  1982), 
which is the first step in the pathway leading to addition of 
high-mannose (Man) oligosaccharide units to certain aspara- 
gine residues in glycoproteins. In the presence of tunicamy- 
cin (Fig. 3 B, panel e), cells synthesized and secreted a 40- 
kD form of Sp46 (size estimated by coelectrophoresis in SDS 
PAGE with the 40-1d) keratin no.  19 of cultured mesothelial 
cells (Wu and Rheinwald, 1981; Wu et al., 1982; Moll et al., 
1982) (data not shown). Treatment with tunicamycin did not 
result in a significant reduction of either synthesis or secre- 
tion of unglycosylated Sp46 compared with that of the nor- 
mal form by control cells. The apparent 6-kD difference in 
mobility in SDS PAGE indicates that Sp46 probably contains 
two N-glycan units and certainly no more than three, taking 
into consideration a molecular mass of ,02 kD per complex 
N-glycan unit (Kornfeld and Kornfeld,  1985) and the very 
slightly slower predicted mobility of a glycoprotein of this 
size and carbohydrate content in 10% SDS gels as compared 
with that of an unglycosylated protein having the same total 
mass (Segrest and Jackson,  1972). 
The 40 kD form secreted by tunicamycin-treated cells had 
the same charge as the normal translation product of Sp46 
(Fig.  3  B,  panel  e).  As  for most  N-linked  glycoproteins 
(Kornfeld and Kornfeld, 1985), the N-glycan units appear to 
be added to Sp46 as it is being translated, because no 40-kD 
form is normally detectable in cell extracts, even after a very 
brief pulse label (Fig.  3 B, panel a).  Posttranslational pro- 
cessing to a larger and more acidic form is therefore depen- 
dent upon the presence of the added N-glycan. Treatment of 
[35S]Met-labeled  CM  with  neuraminidase  resulted  in  the 
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newly translated, intracellular form (data not shown). Thus 
the change in charge and SDS PAGE mobility that occurs 
posttranslationally  under  normal  conditions  is  a  conse- 
quence of the addition of terminal sialic acid residues. This 
is typically the final step of a trimming and addition process 
in the Golgi apparatus, which converts the initial (GlcNAc)2 
(Man)9  (Glc)3 "high mannose" glycan to the ultimate (GIc- 
NAc)2  (Man)3  (GIcNAc)2  (Gal)2  (Sial)l.2 "complex" glycan 
on many glycoproteins (reviewed in Kornfeld and Kornfeld, 
1985;  Hughes,  1983). 
Preparation and Immunochemical Characterization 
of  Antisera against Sp46 
Mesothelial cells that had grown to confluence in standard 
medium without EGF were refed with medium containing 
0.1%  FCS.  They appeared healthy during a  3-d incubation 
in this low serum medium, and electrophoretic analysis of 
the CM disclosed that the ,'~2 ×  106 cells on each 100-mm 
diam culture dish usually secreted about  10 ~tg of soluble 
S1M6 over the course of 3 d. 
The only other prominent protein secreted by mesothelial 
cells into the CM was fibronectin, and it was synthesized at 
a relatively low rate when the cells were confluent in the ab- 
sence of EGE Most of the total protein in the CM was from 
the FCS (see Figs. 2 and 4 B). No 44--48-kD proteins were 
detectable by  Coomassie  Blue  or  Fast  Green  staining  in 
serum-containing medium that had been incubated for 3 d 
without cells, however (compare lanes 3 and 4 of Fig. 4 B), 
indicating that Sp46 could be purified from CM by prepara- 
tive 1D SDS PAGE (see Materials and Methods). 
A rabbit antiserum (J1) raised against the gel-purified pro- 
tein immunoprecipitated Sp46 from mesothelial cell extracts 
and  from CM  (Fig.  4  A).  A  mouse anti-Sp46  antiserum 
(M3) showed the same specificity for Sp46 in immunopre- 
cipitation when a rabbit anti-mouse IgG antibody was used 
as a bridge between the mouse anti-Sp46 and the protein A 
(data not shown). The rabbit antiserum also recognized the 
unglycosylated  form  of  Sp46,  which  is  synthesized  and 
secreted by cells in the presence of tunicamycin (Fig. 4 A, 
lane 8). Thus the antiserum recognized the polypeptide of 
Sp46, and not only its oligosaccharide. Immunoblotting with 
the rabbit (Fig. 4 B) and mouse (data not shown) antisera dis- 
closed no Sp46 in FCS and no cross-reaction with proteins 
of size other than 46 kD in cell extracts. Reaction of the J1 
antiserum with endoglycosidase F-treated Sp46 also indi- 
cated specificity for the polypeptide portion of the glyco- 
protein. 
lmmunofluorescence Analysis of  Substratura-associated 
Sp46  Immunofluorescence staining  revealed that the sub- 
stratum-associated Sp46 was localized in the vicinity of cells 
as a finely divided or speckled coating (Fig. 5). As expected 
from the electrophoretic analysis described above, release of 
cells with EDTA (Fig. 5 f) or lysis and solubilization of the 
cultures with THS buffer (not shown) left the dish-associated 
material  undisturbed.  Our  time-lapse  video  microscopic 
studies had disclosed that mesothelial cells are mobile, and 
that migrating cells usually extend a very broad ruffled mem- 
brane at their leading edge. Although the quantity of Sp46 
around individual cells varied (as, for example, the two cells 
shown in Fig. 5 c), in sparse cultures Sp46 frequently was 
concentrated in a trail behind the cells (Fig. 5, a and b). Con- 
Figure 2.  Characterization of 
Sp46 as  a  glycoprotein con- 
taining  mannose.  [3H]man- 
nose  labeling: two LP-9 cul- 
tures (confluent, + EGF) wore 
labeled with either [3H]man- 
nose or [35S]methionine. The 
labeled  cultures  were  refed 
with  unlabeled  medium  and 
24 h later the medium was har- 
vested and analyzed by SDS 
PAGE  and  autoradiography. 
Lane 1, [3H]mannose-labeled 
CM; lane 2, 35S[met]-labeled 
CM.  Con A-Sepharose bind- 
ing of Sp46: concentrated mesothelial cell CM (a sample of which 
is shown in lane 3) was mixed with Con A-Sepharose beads. Pro- 
teins remaining unbound and in solution are shown in lane 4. Pro- 
teins bound to the Con A-Sepharose beads and eluted by 0.5 M 
u-methylmannoside are shown in lane 5. Samples were separated 
by SDS PAGE  and stained with Coomassie Blue. Asterisk indicates 
Sp46; b indicates BSA. 
sidering the rate of Sp46 dissociation from the substratum 
(Fig.  1), such trails probably represent the migratory paths 
of cells during the 3-6 h preceding fixation. 
The cytoplasm of the cells also was stained, but the very 
flat periphery of mobile cells and the underlying substratum 
in these areas were unstained (Fig. 5, d and e). Mesothelial 
cells spread out and become more flattened as they approach 
confluency in the absence of EGF (Connell and Rheinwald, 
1983).  In  such  cultures,  regions  of the  substratum  unoc- 
cupied by cells at the time of fixation stained rather uni- 
formly for Sp46, whereas the areas occupied by cells stained 
more heterogeneously (Fig. 5, e and g). The peripheral mar- 
gins of some of  the cells were unstained as was also a dartlike 
pattern at the cell-substratum interface of large, less motile 
cells. 
Sp46 Deposition Is Distinct from That of Fibronectin. 
We  compared the  distribution  of fibronectin with  that of 
SIM6 in mesothelial cell cultures by double-label indirect im- 
munofluorescence (Fig. 5, g and h). Little fibronectin stain- 
ing was observed in sparse cultures, but as cells approached 
confluence in the presence of EGF they deposited fibronectin 
in great abundance as fibers and fibrous blobs. Most of the 
fibronectin  was  cell,  rather  than  substratum,  associated. 
"Optical sectioning" by examining cultures at different focal 
planes revealed that the fibronectin fibers were primarily on 
the dorsal surface of the cells, rather than beneath the cells 
as was Sp46. The smooth, even deposition of Sp46 also con- 
trasted with the particulate and fibrous deposits of fibronec- 
tin. When cultures were fixed in 3.7 % formaldehyde and per- 
meabilized with 0.5 % Triton X-100, the patterns of Sp46 and 
fibronectin deposition were the same as observed in metha- 
nol-fixed cultures (data not shown). Thus Sp46 does not ap- 
pear to have a  special affinity for fibronectin. 
Cell 1~e Specificity of Sp46 Synthesis  and Secretion. 
We compared Sp46 synthesis by a variety of normal human 
cell types in culture with that of mesothelial cells in three 
ways:  (a)  [35S]methionine  incorporation into Sp46 relative 
to total cell protein synthesis as analyzed in 2D gels of pulse- 
labeled cell extracts; (b) the amount of labeled Sp46 present 
in the culture medium relative to that in total cell protein 18 h 
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ing, and secretion of Sp46 by 
growing and  quiescent cells. 
LP-9  cultures,  either  sub- 
confluent and rapidly growing 
in  the  presence  of EGE  or 
confluent and quiescent in the 
absence of EGE were labeled 
with  [35S]methionine.  They 
then were either lysed in THS 
immediately (pulse  cultures) 
or at various times after re- 
feeding with unlabeled medi- 
um (chase cultures). The me- 
dium from chase cultures was 
also harvested. Proteins were 
separated  on  2D  NEPHGE 
gels  and  autoradiographed. 
(NEPHGE was run from fight 
to  left  toward  the  negative 
electrode. Basic proteins are 
on  the  left and  more  acidic 
proteins are on the fight.) (A) 
Panels a-d show THS-soluble 
proteins from 1-h pulse cul- 
tures ([a] with EGF, precon- 
fluent; [b] without EGF, post- 
confluent) and from a 1-h pulse/ 
16-h chase  culture  ([c]  with 
EGF, preconfluent), and CM 
from  a  1-h  pulse/16-h  chase 
culture  ([d]  without  EGE 
postconfluent).  Panels  e  and 
f  are gels of a different exper- 
iment  showing  total  protein 
from a  1-h pulse-labeled con- 
fluent  culture  (e),  and  CM 
from  a  similar pulse/chased 
culture (f). The gel in panel f 
is overloaded to show the mi- 
nor, more acidic form of Sp46 
and the position of the small 
amount  of  actin  present  in 
CM. (B [right page]).  The Mr 
35-60-kD/pI  5.3-7.8  regions 
of 2D NEPHGE separations. 
THS-soluble fraction from (a) 
a 20-min pulse culture and (b) 
a  1-h pulse culture; (c) THS- 
insoluble fraction from a 20- 
min pulse/2-h chase culture; 
(d) immunoprecipitate of 1-h 
pulse-labeled  extract  using 
rabbit  anti-Sp46  antiserum; 
(e) medium as in d except that 
the  culture had  been treated 
with 2 gg/ml tunicamycin for 
2 h before and during the 1 h 
of labeling; (f) idealized dia- 
gram of Sp46 synthesis, gly- 
cosylation, and processing before secretion. (Hatched oval)  The unglycosylated form of Sp46,  which only occurs in the presence of 
tunicamycin. (Solid oval) The normally secreted form of Sp46.  After translation and the initial N-glycosylation, additional processing, 
including terminal sialation, occurs in mesothelial cells during the next 1-2 h to make Sp46 apparently 1 kD larger (as estimated by SDS 
PAGE mobility)  and '~0.3 pH units more acidic before it is secreted. Arrowheads indicate the several intracellular  forms of S1M6; Tindicates 
the form of Sp46 synthesized and secreted in the presence of tunicamycin; V indicates vimentin (Mr 57 kD/pI 5.2); arrows indicate the 
four keratins (nos. 7, 8, 18, and 19) of Mr 55, 52, 44, and 40 kD synthesized by mesothelial cells; asterisks are below ffactin (Mr 43 kD/pI 
5.4); FN is below fibronectin. 
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sociated Sp46 near cells in sparse cultures as detected by im- 
munofluorescence microscopy. These three methods yielded 
the same results for comparative Sp46 production among the 
cell types examined, but the level of labeled Sp46 appearing 
in CM was the easiest method to quantitate. A sample experi- 
ment is shown in Fig. 6 A, and the results of all analyses are 
summarized in Table I. Umbilical vein endothelial cells ex- 
pressed Sp46 at levels  similar to that of mesothelial  cells. 
Type II renal cortex epithelial cells (Rheinwald and O'Con- 
nell,  1985) expressed about half as much, and Type I renal 
cortex epithelial cells about one-fifth as much as mesothelial 
Figure 4.  Immunoprecipitation and immunoblot analysis  of Sp46. 
(A)  Immunoprecipitation  of Sp46  from  [35S]methionine-labeled 
LP-9 cells and CM. Lane 1: the THS-soluble cell fraction, and the 
proteins  precipitated  by rabbit anti-Sp46 antiserum (lane 2) or by 
preimmune serum (lane  3).  Lane 4: labeled  (pulse-chased)  CM, 
and the proteins precipitated  from it by rabbit anti-Sp46 antiserum 
(lane 5) or by preimmune serum (lane 6). Lane 7: labeled  (pulse- 
chased)  CM  from  tunicamycin-treated  cells,  and  the  proteins 
precipitated  from it by rabbit anti-SIM6  antiserum (lane 8) or by 
preimmune serum (lane 9). Arrowhead indicates  Sp46; T indicates 
the smaller  (40 kD) form of Sp46 synthesized  and secreted  in the 
presence oftunicamycin. (B) Immunoblot detection of  Sp46. Upper 
panel: Fast Green-stained  proteins electrotransferred  to nitrocellu- 
lose paper from a gel of 1D SDS PAGE. Lower  panel: the same blot 
after incubating with rabbit anti-Sp46 serum and developing  with 
avidin-biotin  complex peroxidase  and  diaminobenzidine  (a blue 
filter was used during photography of the lower panel to block out 
the Fast  Green color).  (Note: an identical  blot treated with  pre- 
immune rabbit serum antibody was absolutely  unstained  by immu- 
noperoxidase).  Lane 1,  SDS-soluble proteins from bladder uro- 
thelial  cell  strain  HB1-4; lane  2,  SDS-soluble  proteins  from 
mesothelial  cell strain  LP-9; lane 3, concentrated LP-9 CM; lane 
4, concentrated, serum-containing medium that had been incubated 
without cells for 3 d; lane 5, SDS-soluble proteins remaining on the 
dish after the mesothelial  cells from a confluent culture had been 
detached by incubation with EDTA; lane 6, purified  Sp46; lane 7, 
purified  Sp46 incubated  as in lane 8 but without endoglycosidase 
F; lane 8, purified  Sp46 after incubation with endoglycosidase E 
Arrowheads indicate  Sp46; E  indicates  the 40-kD form of Sp46 
resulting  from treatment with endoglycosidase E 
Rheinwald et al. Glycoprotein  of Mesoderm-derived Epithelial Cells  269 Figure 5. Immunofhorescence  localization of Sp46 in mesothelial cultures. Panels a, c, d, e, andfshow staining with the J1 rabbit antiserum. 
Panel b is phase-contrast  illumination  of the field shown in panel a. Panels a-d are preconfluent  cultures,  with EGE Panels e and fare 
confluent cultures,  without EGF; the culture in panel fwas treated with EDTA to release the cells before fixation. Panels g and h are the 
same field of a confluent culture, with EGF, stained with M3 mouse anti-Sp46 antiserum and rhodamine secondary antibody (g), and 
rabbit anti-human  fibronectin  antiserum (Cappel Laboratories,  Inc., Malvern, PA) and fluorescein secondary antibody (h). Arrows indicate 
the leading edge and arrowheads  the trailing edge of motile cells in panels a-d. Asterisks  in panels e and g indicate an area of the dish 
unoccupied by cells at the time of fixation. Bar in panel a indicates 50 gtm, showing magnification  for all panels except panel e, which 
contains its own 50-1am standard. 
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Cell Types in Culture 
Cell type (number of strains tested)  Relative Sp46 synthesis 
Mesothelial (3)  80-120 
Vein endothelial (2)  80-1(10 
Kidney tubule, type II (2)  40-50 
Kidney tubule, type I (1)  20 
Dermal fibroblast (3)  8-15 
Epidermal keratinocyte (2)  <3 
Bladder urothelial (2)  <3 
Conjunctival epithelial (1)  <3 
Mammary epithelial (2)  <3 
Data were compiled from experiments as described in legend to Fig. 6. Each 
strain was examined both by 1D SDS PAGE of pulse-chased CM and by 2D 
NEPHGE of pulse-labeled whole-cell extracts. 
Figure  6.  Cell  type  specificity  of  Sp46  synthesis.  (A)  Near- 
confluent,  exponentially growing cells  were labeled  for 1 h with 
[35S]methionine and refed with unlabeled medium.  18 h later, the 
CM was harvested and the cells were dissolved in Laemmli lysis 
buffer. Samples of  labeled CM from each cell type (volumes loaded 
were adjusted to normalize for differences among the cell types in 
incorporation  of label into total cell protein) were then separated 
by 1D SDS PAGE and autoradiographed on preflashed film. Lane 
1, mesothelial  strain LP-9; lane 2, dermal  fibroblast strain R2-F; 
lane 3, epidermal keratinocyte strain N; lane 4, bladder urothelial 
strain HBI-4; lane 5, kidney cortex type I epithelial strain HKi-12 
clone D; lane 6, kidney cortex type II epithelial strain HKi-12 clone 
2.1; lane 7, kidney cortex type II epithelial strain HKi-14 clone 8; 
lane 8, a 1:16 dilution of the LP-9 CM sample shown in lane 1. Ar- 
rowhead indicates Sp46. FN indicates fibronectin, which is synthe- 
sized at relatively  high  rates by mesothelial  cells  when  they are 
growing rapidly in the presence of EGF, as in this experiment, but 
at much lower rates by cells that are quiescent  in the absence of 
EGE (B) Immunoblot detection and quantitation of Sp46 in CM 
from human and orangutan cells. 3-d CM was harvested from cul- 
tures  containing  3-6  x  106 cells  per  100-mm dish.  Cells  were 
grown in the presence of 0.4 ~tg/ml  HC. The CM was concentrated 
50-fold and samples were separated by SDS PAGE, electrotrans- 
ferred to nitrocellulose paper, and reacted with rabbit anti-Sp46 an- 
tiserum and avidin-biotin complex peroxidase. Lane 1, 5 Ixl of 50- 
fold concentrated LP-9; lanes 2-4, serial threefold dilutions of the 
LP-9 CM sample of lane 1; lane 5, 5 Ixl of 50-fold concentrated un- 
conditioned  medium;  lane  6,  10 ~tl of 50-fold concentrated  CM 
from human fibroblast strain R2-F; lane 7, 10 ttl of 50-fold concen- 
trated CM from orangutan fibroblast strain OrangF-1. 
cells. Connective tissue fibroblasts secreted about 1/10th as 
much as mesothelial cells. Sp46 synthesis by fibroblasts, but 
not by mesothelial cells, was dependent upon HC: in the ab- 
sence  of  HC,  fibroblasts  reduced  their  Sp46  production 
about threefold. 
Epidermal keratinocytes, conjunctival epithelial cells, blad- 
der urothelial  cells,  and mammary epithelial  cells did not 
produce Sp46 at detectable levels (<3 %  that produced by 
mesothelial cells). Except for the effect of HC on fibroblasts, 
culturing cells in different media did not markedly affect the 
level of Sp46 synthesis: fibroblasts synthesized Sp46 at the 
same rate when growing in DME/F12 as in M199/MCDB202 
medium, and mammary epithelial cells failed to produce de- 
tectable amounts of Sp46  when growing either in the  313 
feeder system or in standard medium plus EGE Thus epithe- 
lial cells and epithelial-like cells (i.e., endothelial cells) of 
embryonic mesodermal origin synthesize and secrete large 
amounts of Sp46 but other epithelial cell types do not. Im- 
munoblot analysis failed to detect Sp46 in ascites fluid of the 
peritoneal cavity, in pleural effusion fluid, or in homogenates 
of mesotheliomas or of normal human fetal kidney. Sp46 was 
not  detected  immunohistologically  in  cryostat or  paraffin 
sections of normal kidney or of mesotheliomas. 
We did not detect metabolically labeled Sp46 in the pre- 
sumptive rat mesothelial cell line RM-4 (ATCC No. CCL216) 
(Aronson  and  Cristofalo,  1981), in  a  presumptive bovine 
mesothelial cell strain (AG4907 of the Corielle Institute for 
Medical Research), in the bovine endothelial cell line ABAE 
(Gospodarowicz et al., 1976), in the kangaroo rat kidney epi- 
thelial cell line PtK2, in the canine kidney epithelial cell line 
MDCK, in the Swiss mouse fibroblast line 3T3 (Todaro and 
Green,  1963),  or in early passage cultures of normal rabbit 
mesothelial or kidney cortex epithelial cells.  Nor were we 
able  to  detect  immunologically  cross-reacting  protein  in 
Western blots of concentrated CM harvested from these cul- 
tures. In contrast, normal orangutan fibroblasts synthesized 
and  secreted  a  protein  of identical  size,  charge,  and  im- 
munoreactivity as human Sp46 and at levels similar to that 
of human fibroblasts (Fig. 6 B). Normal owl monkey and le- 
mur catta fibroblasts also secreted a protein identifiable elec- 
trophoretically as Sp46. 
Amino Acid Analysis and Amino-terminal Sequencing 
of Sp46~ To concentrate and increase the purity of Sp46 be- 
fore preparative electrophoretic isolation,  concentrated hu- 
man mesothelial cell CM  was bound to Con A-Sepharose 
beads and eluted with ct-methylmannoside, as described in 
Fig.  2.  The eluted proteins could be loaded onto slab gels 
such that 20  Ixg of Sp46 separated cleanly from other pro- 
teins in each lane. 75 ~tg of electroeluted Sp46 was used for 
amino acid analysis and 75 ~tg for amino-terminal sequenc- 
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*Approximate  number of 
*mol%  residues per molecule 
Glu/Gln  11.5  42 
Asp/Asn  8.9  32 
Ser  8.3  30 
Thr  8.3  30 
Tyr  1.4  5 
Gly  6.5  24 
Pro  2.1  8 
Val  9.0  33 
Leu  8.9  32 
Ile  4.1  15 
Ala  5.8  21 
Phe  5.7  21 
Met  1.1  4 
His  4.1  15 
Lys  4.4  16 
Arg  8.1  30 
Trp  ND~  ? 
Cys  ND  ? 
* The contents  of Tip and Cys were each assumed to be  1% for calculating 
moles% and residues per molecule of the other amino acids. 
~: ND, not determined. 
ing, performed by Dr. David Andrews and Dr. William Lane 
of the protein sequencing facility at the Harvard Biological 
Laboratories. Sp46 was found to contain only 6.5 mol% gly- 
cine, corresponding to approximately 24 residues per 40-kD 
polypeptide (Table H).  Thus Sp46 cannot have a  lengthy 
(GIy-X-Y). repeat sequence as collagens possess (see review 
by Martin et al., 1985), and is therefore unlikely to be a col- 
lagenlike protein. The mobility of Sp46 was identical under 
reducing or nonreducing conditions (with and without 2-mer- 
captoethanol) in SDS PAGE; thus the protein is unlikely to 
have extensive intrachain disulfide bonds (see Sage et al., 
1984) nor does it exist in the medium as larger disulfide- 
bonded aggregates. 
The NH2-terminal sequence of Sp46 was determined for 
the first 40 amino acids by automated Edman degradation 
(Fig.  7).  The repetitive yield during  the  sequencing was 
>193%.  The sequence was  compared with  all protein se- 
quences in the National Data Base by E Temple Smith of this 
institute, and was not identical or closely related to any se- 
quence in that library. About half of the Sp46 molecules in 
the sample, which was purified from 3-d CM, lacked the first 
two amino acid residues of the NH2-terminal end.  We do 
not know whether there are alternate cleavage sites for the 
intracellular removal of a  signal sequence, or whether the 
protein is subject to proteolysis after secretion. 
Discussion 
Sp46 is the predominant protein secreted by human meso- 
derm-derived epithelial and endothelial cells in culture, and 
we therefore propose for it the name "mesosecrin" Except 
for 13-actin, mesosecrin is synthesized at a higher rate than 
any other protein by mesothelial cells, representing several 
percent of total protein synthesis. 
Mesosecrin  is  a  glycoprotein, containing  two  or three 
N-glycan units. These oligosaccharides are processed before 
secretion, with the addition of terminal sialic acid residues 
val -al a-(va I )-hi s-hi s-pro-p ro-ser-tyr- 
val -al a-hi s-I eu-al a-ser-a sp-p he-gl y- 
va I -a rg-va I -p he-g I n -g I n -va I -a I a -g I n- 
al a-ser-I ys-asp-arg-a sn-va I -val -phe- 
(?) -pro-tyr-(g  I y)-val -al a- 
Figure 7. Amino acid sequence of the NH2-terminal end of Sp46. 
Sequence determined by automated Edman degradation of Sp46 
purified from medium conditioned by human mesothelial cell strain 
LP-9. Residues in parentheses are uncertain. The residue indicated 
by (~ could not be determined. About half the Sp46 molecules in 
the sample were missing the first two amino acid residues from the 
NH2-terminal end. 
resulting in the protein becoming more acidic and exhibiting 
a slightly decreased ('~1  kD) mobility in SDS PAGE. Many 
N-glycans undergo such  terminal  sialation when they are 
converted in the Golgi apparatus from the initial "high man- 
nose" form to the ultimate "complex" form (Kornfeld and 
Kornfeld,  1985).  Mesosecrin apparently is not O-glycosyl- 
ated, nor is the polypeptide portion modified in any way that 
would affect its charge or mobility in SDS PAGE,  because 
the N-glycan-deficient form of mesosecrin synthesized in the 
presence of tunicamycin does not change in size or charge 
from the time it is translated until it is secreted. Mesosecrin 
in mesothelial cells would be an excellent system for study- 
ing the regulation of glycoprotein synthesis, N-glycan pro- 
cessing, and secretion because mesosecrin is synthesized at 
very high levels by these cells, all forms of mesosecrin are 
well resolved from other major cell proteins in 2D NEPHGE 
gels, and a polypeptide-specific antiserum is available. 
Mesothelial cells modulate their synthesis and content of 
intermediate filament proteins over an extraordinarily wide 
range as a function of their proliferative state (Connell and 
Rheinwald, 1983). Mesothelial cells have a high rate of syn- 
thesis and acquire a very high content of the four simple epi- 
thelial keratins when they become replicatively quiescent in 
the absence of their essential growth factor EGE When they 
are rapidly dividing in the presence of EGE they synthesize 
and acquire high levels of vimentin, and greatly reduce their 
rate of synthesis and consequently their content of keratins. 
In this study we found that fibronectin synthesis and secre- 
tion were also modulated, being much greater during rapid 
growth in the presence of EGF than during quiescence in the 
absence of EGE  Because  of their differential expression 
among cell types, mesosecrin synthesis and secretion also 
can be classified as differentiated functions. However, they 
do not ~ary in mesothelial cells as a function of the EGF- 
dependent proliferative state. Fibroblasts make some meso- 
secrin, and it is perhaps for this reason that mesosecrin syn- 
thesis  does  not  become  suppressed,  as  keratin  synthesis 
does, when mesothelial cells and type II kidney epithelial 
cells are in a dedifferentiated, "fibroblastoid" state. 
Some  pulse-labeled  mesosecrin  is  found  in  the  THS- 
insoluble protein fraction along with some of the total cellu- 
lar fibronectin, actin,  and all of the intermediate filament 
protein of the mesothelial cells. In an earlier communication 
reporting our characterization of the four simple epithelial 
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a keratin (Wu et al., 1982). In that early investigation we did 
not use protease inhibitors; in retrospect it seems certain that 
the 46-kD  mesothelial protein that had keratin properties 
observed in experiments employing 1D gels was the promi- 
nent 46-kD breakdown product of the 52-kD keratin no.  8 
(Schiller and Franke,  1983), which results from the action 
of an  endogenous  Ca2+-dependent  protease  (Nelson  and 
Traub,  1981). 
Several  secreted glycoproteins have been described re- 
cently that possess  several N-glycan units and migrate in 
SDS-PAGE  as molecules of Mr 40-50  kD.  We have been 
able to rule out an identity of these proteins and mesosecrin. 
The 47-kD glycoprotein colligin (Kurkinen et al., 1983; Tay- 
lor et al., 1985) is much more basic than mesosecrin, is cell 
surface-associated, and binds to gelatin. The 43-kD secreted, 
acidic, cysteine-rich glycoprotein SPARC produced by bo- 
vine aortic endothelial cells (Sage et al., 1984) and by mouse 
parietal endoderm ceils (Mason et al.,  1986) has an amino 
acid composition and sequence very different from mesose- 
crin. The 43-kD protease-nexin (Baker et al., 1980) secreted 
by human fibroblasts has an amino acid composition and 
NH2-terminal sequence (Scott et al.,  1985) very different 
from mesosecrin. Endothelial cells produce a 50-kD plas- 
minogen-activator inhibitor (van Mourik et al., 1984; Erick- 
son et al., 1985), but its pI is 4.5-5.0, which is very different 
from mesosecrin. MEP, a 39-kD major excreted protein of 
transformed NIH 3T3 cells (Gal et al., 1985) is much smaller 
than Sp46  and does not appear to associate with the sub- 
stratum. 
We did not detect mesosecrin as  a  protein  secreted in 
amounts detectable autoradiographically  by several mesothe- 
lial, endothelial, kidney epithelial, and fibroblast cell lines 
of rodent, rabbit, canine, or bovine origin. Mesosecrin was 
expressed, however, by orangutan fibroblasts. An additional 
factor might be required to induce mesosecrin expression in 
culture by cells of the nonprimate species examined. Alter- 
natively, mesosecrin may have appeared rather late in evolu- 
tion and may be restricted to primates,  such as has been 
found for involucrin,  the major  structural protein  of the 
epidermal cornified envelope (Banks-Schlegel and Green, 
1980; Rice and Thacher,  1986). 
The cell type specificity of mesosecrin synthesis is in- 
teresting.  It  groups  several  true  epithelial  (i.e.,  keratin- 
containing) cell types with the large vessel endothelial cell, 
which adopts an epithelioid morphology but contains vimen- 
tin rather than keratin filaments. Before the application of 
anti-intermediate filament immunohistochemistry and our 
own cell culture studies, many medical histologists consid- 
ered mesothelial and endothelial cells to be virtually indis- 
tinguishable cell types (for example,  see Reith and Ross, 
1977; Leeson and Leeson,  1979), which serve the similar 
functions of presenting nonthrombogenic, nonadhesive sur- 
faces to the blood and serous fluids, respectively. Cell culture 
studies have clearly demonstrated, however, that normal hu- 
man endothelial and mesothelial cells differ greatly in their 
hormone and growth factor requirements (Thornton et al., 
1983;  Connell and Rheinwald,  1983),  in addition to their 
differences in intermediate filament expression.  Neverthe- 
less, the abundant secretion of mesosecrin tends to group 
these two functionally similar cell types together again. 
Mesosecrin is also expressed at high levels by kidney tu- 
bule epithelial cells, which are very different structurally and 
functionally from mesothelial and endothelial cells in vivo, 
but which have a similar embryonic origin. When the neph- 
rons form during embryogenesis, the nephrogenic cells in a 
region of the mesoderm change from a  fibroblastoid cell 
type, which had expressed vimentin and fibronectin, to an 
epithelioid cell type, which thenceforth expresses keratins 
and laminin (Holthofer et al.,  1984; reviewed by Ekblom, 
1984). Two morphologically distinctive cell types grow from 
explants of either fetal or adult kidney cortex: a high kera- 
tin/low vimentin epithelioid cell (type I), which forms tight- 
ly adherent colonies,  and a  low-to-moderate keratin/high 
vimentin cell (type II), which forms dispersed colonies of 
morphology similar to that of mesothelial cells (Rheinwald 
and O'Connell, 1985; Rheinwald et al., 1984). Type II kid- 
ney cells are less dependent upon exogenous growth factors 
and a complex nutrient medium than are mesothelial cells, 
but they still express high levels of vimentin during growth 
in culture and modulate their expression of keratins some- 
what as a function of growth. We have found here that they 
also resemble mesothelial cells in the high level synthesis of 
mesosecrin. 
The initial substratum association ofmesosecrin is consis- 
tent with its being an extracellular matrix protein located at 
the basal surface of cells that synthesize it.  The exclusive 
deposition onto the substratum, without any of the secreted 
protein escaping directly into the medium, is remarkable. It 
occurs  even in  sparse  cultures of migrating cells,  which 
would not be expected to have a polarized secretory appara- 
tus, and it occurs on both positively and negatively charged 
substrata. Virtually all of the mesosecrin synthesized ends up 
in solution in the medium, but this is also the fate of much 
of the fibronectin and collagen synthesized by cells growing 
on tissue culture plastic. In vivo localization data will be re- 
quired, of course, to determine the significance of the initial 
substratum-association in culture. The smooth, even deposi- 
tion of mesosecrin on the culture substratum contrasts with 
the fibrous, supracellular organization of fibronectin, and in- 
dicates that mesosecrin neither self-assembles nor combines 
with fibronectin to form higher-order structures detectable 
by light microscopy. Its lack of binding to gelatin-Sepharose 
indicates that mesosecrin does not have a binding site for 
type I  collagen similar  to  that of fibronectin (Hahn and 
Yamada,  1979), colligin (Kurkinen et al., 1984), or the gly- 
cine-rich gelatin-binding protein of porcine plasma (Isemura 
et al.,  1982),  all of which recognize denatured collagen. 
Because of the present lack of an easily accessible animal 
model, we have no data as yet on the distribution of mesose- 
crin in vivo. We may have unmasked by growth in culture a 
potential of mesoderm-derived cells for extraordinarily high 
rates of mesosecrin synthesis, which usually does not occur 
under normal steady-state conditions in vivo. We are not yet 
in a position even to guess at its function. Mesothelial cells 
attach and spread very rapidly after plating on tissue culture 
plastic, presumably before much mesosecrin could be depos- 
ited. Preliminary experiments indicate that anti-mesosecrin 
antiserum does not inhibit the initial attachment and spread- 
ing  of subcultured mesothelial cells,  but causes  them to 
round up and detach within a day after plating (K. Plummer 
and J.  Rheinwald, unpublished observations).  We do not 
know whether this result has significance beyond the general 
inability of ceils to adhere to antibody molecules that have 
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1978). Considering the types of cells that express mesose- 
crin, it would be interesting  to determine whether the protein 
plays  a role in cell-substratum  adhesion,  enhancement or 
inhibition of blood clotting,  or growth regulation.  Nilsen- 
Hamilton and Holley (1983)  have reported that the African 
green monkey kidney cell line BSC-1  cultured in low serum 
medium secretes a 48-kD protein in response to treatment 
with transforming  growth  factor-13. We have  found an Mr 
45-kD/pI 7.2 protein secreted by BSC-1  which may cross- 
react with our anti-human mesosecrin antiserum, but we do 
not know whether its  synthesis is subject to regulation by 
transforming  growth factor-J3. 
Regardless of its function,  mesosecrin may have  an im- 
mediate practical application. Five of the six human meso- 
thelioma cell lines that we have tested all secreted moderate- 
to-high levels of mesosecrin in culture, whereas four squa- 
mous cell carcinomas  of oral and epidermal origin,  HeLa 
cells, and MCF-7 cells did not (J. Rheinwald and A. Terpstra, 
manuscript in preparation).  Thus mesosecrin may serve as 
a diagnostic marker to aid in identifying the cell type of ori- 
gin of certain  malignancies. 
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